Development of new drug delivery solutions.
Business Challenge
Changes in the drug delivery market led to uncertainty concerning the use of pMDIs as a drug delivery system for inhalation products. The development priorities for new pMDI hardware technologies were required from both pharmaceutical manufacturers and clinics.
Solution
50 qualitative telephone depth interviews each taking 1 hour, took place with consultants, developers and licence staff in pharmaceutical organisations, hospitals and patient groups throughout Europe and the US .
Results
The findings enabled the client to establish the future development path for inhalation drug delivery solutions.
